Financial writer recommends buying Elevance Health stock despite recent drop, citing strong industry trends and potential for significant upside.

Elevance Health Inc (ELV) reports robust financial performance with a focus on strategic growth and shareholder returns, despite challenges in Medicaid cost trends.

Please go ahead. Nathan Rich-- Vice President, Investor Relations Good morning, and welcome to Elevance Health fourth quarter 2024 earnings call. My name is Nathan Rich, vice president of investor ...

We recently published a list of 12 Best Health Insurance Stocks to Buy in 2025. In this article, we are going to take a look ...

Please go ahead. Good morning, and welcome to Elevance Health's fourth quarter 2024 earnings call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on the ...

Please go ahead. Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan Rich, Vice President of Investor Relations. With us this morning on ...

Elevance Health Inc. (NYSE:ELV) Q4 2024 Earnings Call Transcript January 23, 2025 Elevance Health Inc. beats earnings expectations. Reported EPS is $3.84, expectations were $3.8.

I would now like to turn the conference over to the company's management. Please go ahead. Good morning, and welcome to Elevance Health fourth-quarter 2024 earnings conference call. My name is Nathan ...